Pulmonary Hypertension in COPD: Pathophysiology and Therapeutic Targets

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|12|4|501-513

ISSN： 1389-4501

Source： Current Drug Targets, Vol.12, Iss.4, 2011-04, pp. : 501-513

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antioxidant Therapeutic Targets in COPD

By  

Current Drug Targets, Vol. 7, Iss. 6, 2006-06 ,pp. : 707-720

Bentham Science Publishers

Access to resources Recommend Favorite

Pulmonary Hypertension in Patients with Chronic Obstructive Pulmonary Disease: Advances in Pathophysiology and Management

By >   Blanco Isabel  

Drugs, Vol. 69, Iss. 9, 2009-06 ,pp. : 1153-1171

Adis International

Access to resources Recommend Favorite

Pathophysiologic therapeutic targets in hypertension: a cardiological point of view

By Fragasso Gabriele   Maranta Francesco   Montanaro Claudia   Salerno Anna   Torlasco Camilla   Margonato Alberto  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 2, 2012-02 ,pp. : 179-193

Informa Healthcare

Access to resources Recommend Favorite

TRP Channels as Therapeutic Targets in Kidney Disease and Hypertension

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 3, 2013-02 ,pp. : 386-397

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of pulmonary arterial hypertension with bosentan: from pathophysiology to clinical evidence

By Provencher Steeve   Sitbon Olivier   Simonneau Gérald  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 8, 2005-07 ,pp. : 1337-1348

Informa Healthcare

Access to resources Recommend Favorite